VERBIO Vereinigte BioEnergie AG (VBK) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of VERBIO Vereinigte BioEnergie AG €16.98, price €26.72, upside -36.5%, quality 69 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch VERBIO Vereinigte BioEnergie AG for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 1, 2026.
How to read this chart
60‑month range €7.58 – €83.61 · fair‑value band €12.73 – €21.22 · the €26.72 price screens above the €16.98 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 1, 2026.
Follow VERBIO Vereinigte BioEnergie in your weekly email
Every Wednesday you see whether VERBIO Vereinigte BioEnergie is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Verbio SE engages in the production and distribution of fuels and finished products in Germany, Europe, North America, and internationally. It operates through Biodiesel, Bioethanol/Biomethane, and Other segments.
Show more
Verbio SE engages in the production and distribution of fuels and finished products in Germany, Europe, North America, and internationally. It operates through Biodiesel, Bioethanol/Biomethane, and Other segments. The company provides bio-based chemicals, biodiesel, pharma-glycerine, biomethane, and bioethanol; olefin metathesis catalysts; animal feeds, such as Verbio Proti Flow and Verbio Grain Pro; phytosterols under the Sterocellent brand; and fertilizers. It also offers trading, and transport and logistics services. The company's products are used for cosmetics, food, pharmaceuticals, heat and power generation, fuels, renewable chemicals, aromas and fragrances, plastics, agrochemicals, and agriculture applications. It serves oil, oil mills, pharmaceuticals, trading and logistics, transport and fleet operators, energy utilities, farmers, LNG/CNG filling stations/retail, and other industries. The company was formerly known as VERBIO Vereinigte BioEnergie AG and changed its name to Verbio SE in December 2023. Verbio SE was founded in 2006 and is based in Leipzig, Germany.
Stock analysis
VERBIO Vereinigte BioEnergie AG (VBK) currently trades at €26.72, while our model-based Fair Value estimate is €16.98, 36.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €24.36 per share, and 7 of the 26 models we run sit above the €26.72 price.
Bear case: the Dividend Discount group reads lowest at €3.01, and 19 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: €12.73 (bear) to €21.22 (bull), the price of €26.72 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
VERBIO Vereinigte BioEnergie AG reported revenue of €1.9B in FY2026 versus €1.8B in FY2022, a compound +0.8%/yr. Reported net income was €63.9M in FY2026, compounding −32.9%/yr from FY2022.
Key figures
Market cap €1.8B · P/E ratio 26.7 · P/S ratio 0.91 · EPS (TTM) €1.00 · Dividend yield 0.7% · Net margin 3.4% · Return on equity 8.2% · Return on assets (EBIT) 12.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 143% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −36%, VBK screens cheaper than that median.
Fair Value models
Bear €12.73Fair Value €16.98Bull €21.22
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 3 months old). Earnings retained since then (€0.2575 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.83/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+18.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.8%
Start year 2021 (pandemic). Over 10 years: +11.1% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−7.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.9%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−7.9% vs 2.3%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 7%
Start year 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+12.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +10.3% a year for the price and +6.1% for the forecasts.
Compare VERBIO Vereinigte BioEnergie AG with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 710 stocks
Beats the industry median on 7/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside−36.5% · Below median
Profitability
Return on equity (TTM)8.2% · Above median
Return on assets5.7% · Top 25%
Net margin (TTM)3.4% · Below median
Operating margin (TTM)11.7% · Above median
Growth and dividend
Revenue growth22.7% · Above median
Dividend yield (TTM)0.7% · Below median
Balance sheet
Debt / equity0.21× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)26.7× · Pricier than median
P/B2.15× · Pricier than median
P/S (TTM)0.94× · Cheaper than median
P/FCF22.4× · Pricier than median
EV/EBITDA10.4× · Cheaper than median
PEG5.80× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 44
PAST (return on equity)33· sector 25
HEALTH (low debt)89· sector 95
DIVIDEND (yield)14· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "VERBIO Vereinigte BioEnergie AG Fair Value". https://www.fairvalue-calculator.com/stock/VBK
Frequently asked questions
Is VERBIO Vereinigte BioEnergie AG (VBK) overvalued or undervalued?
As of Oct 1, 2026, our model estimates a fair value of €16.98 versus a price of €26.72, about −36% upside (overvalued).
What is the fair value of VBK?
Our model-based fair value for VERBIO Vereinigte BioEnergie AG is €16.98 (as of Oct 1, 2026), built from audited fundamentals. The current price: €26.72.
What is the quality score of VBK?
VERBIO Vereinigte BioEnergie AG has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for VERBIO Vereinigte BioEnergie AG (VBK)?
Our model-based price target is the fair value of €16.98 (as of Oct 1, 2026) from 26 valuation models. Cautious scenario €12.73, optimistic scenario €21.22. It is a calculation from audited fundamentals, not an analyst target.
What is the VERBIO Vereinigte BioEnergie AG stock forecast for 2026?
Our models put fair value at €16.98, about −36% upside versus a price of €26.72 (overvalued). Cautious scenario €12.73, optimistic scenario €21.22. The calculation is refreshed regularly with new filings.
What is the revenue of VERBIO Vereinigte BioEnergie AG (VBK)?
VERBIO Vereinigte BioEnergie AG reported trailing-twelve-month revenue of about €1.9B (latest available figure, as of Oct 1, 2026).
Does VERBIO Vereinigte BioEnergie AG pay a dividend?
VERBIO Vereinigte BioEnergie AG currently shows a dividend yield of about 0.71% relative to its recent price (as of Oct 1, 2026).
What growth is priced into VERBIO Vereinigte BioEnergie AG (VBK)?
For today's price to be fair in a discounted-cash-flow model, VERBIO Vereinigte BioEnergie AG would have to grow free cash flow by +12.7 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.8 % per year. As of Oct 1, 2026.
What discount rate (WACC) does the fair value of VBK use?
Our models discount VERBIO Vereinigte BioEnergie AG at 9.5 %: a base by market capitalisation (mid), country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For VERBIO Vereinigte BioEnergie AG that is +12.7 % per year a year over ten years, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has VERBIO Vereinigte BioEnergie AG (VBK) delivered so far?
Over the past 5 years revenue at VERBIO Vereinigte BioEnergie AG grew +12.8 % a year. The price currently implies +12.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of VERBIO Vereinigte BioEnergie AG (VBK) growing?
The median revenue growth in the sector is +5.7 % a year. That is the yardstick for the growth priced into VERBIO Vereinigte BioEnergie AG (+12.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of VERBIO Vereinigte BioEnergie AG (VBK)?
The free-cash-flow yield on the price is 4.47 %: that much free cash flow VERBIO Vereinigte BioEnergie AG produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of VERBIO Vereinigte BioEnergie AG (VBK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For VERBIO Vereinigte BioEnergie AG it is €16.98 per share (as of Oct 1, 2026), against a price of €26.72. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is VERBIO Vereinigte BioEnergie AG stock overvalued or undervalued in 2026?
As of Oct 1, 2026, VBK trades above its calculated fair value: price €26.72, fair value €16.98, a gap of about −36% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VBK?
No. The price is what the market pays today (€26.72); the fair value is what the company's own numbers justify (€16.98). For VERBIO Vereinigte BioEnergie AG the two are €9.74 per share apart. That gap is exactly why we show both numbers side by side.
How much is VERBIO Vereinigte BioEnergie AG worth?
The market values VERBIO Vereinigte BioEnergie AG at about €1.8B (market capitalisation, as of Oct 1, 2026). Per share that is €26.72; our models calculate a fair value of €16.98 per share.
What do the bullish and bearish scenarios say about VBK?
Our models span a range for VERBIO Vereinigte BioEnergie AG: cautious scenario €12.73, base €16.98, optimistic €21.22 per share (as of Oct 1, 2026, price €26.72). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of VBK?
VERBIO Vereinigte BioEnergie AG trades at a price-to-earnings ratio of 26.7 (as of Oct 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €16.98 is built from several models across several years. Other multiples: PEG 5.8, P/B 2.2, P/S 0.9, EV/EBITDA 10.4.
What is the PEG ratio of VBK?
The PEG ratio of VERBIO Vereinigte BioEnergie AG is 5.80 (P/E divided by earnings growth, as of Oct 1, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of VERBIO Vereinigte BioEnergie AG (VBK)?
Balance-sheet figures for VERBIO Vereinigte BioEnergie AG (as of Oct 1, 2026): return on equity 8.2%, debt of 0.21 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is VBK from its 52-week high?
VERBIO Vereinigte BioEnergie AG trades at €26.72, about 42% below its 52-week high of €45.80 and 143% above the low of €11.00 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of €16.98 is for.
Which stocks are comparable to VERBIO Vereinigte BioEnergie AG?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is VERBIO Vereinigte BioEnergie AG stock attractive at the current price?
The data as of Oct 1, 2026: price €26.72, calculated fair value €16.98 (−36%), Quality Score 69/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VBK calculated?
We run VERBIO Vereinigte BioEnergie AG through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €16.98, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. VERBIO Vereinigte BioEnergie AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of VERBIO Vereinigte BioEnergie AG (VBK)?
The closing price on Oct 1, 2026 was €26.72. Our model-based fair value is €16.98, about −36% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with VERBIO Vereinigte BioEnergie AG right now?
The price sits above even our optimistic bull case (€21.22). The favourable scenario is already priced in. Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of VERBIO Vereinigte BioEnergie AG (VBK) come from?
Earnings per share at VERBIO Vereinigte BioEnergie AG grew −0.4 % a year from 2015 to 2026. Broken into its drivers: revenue per share +11.1 %, EBIT margin −3.3 %, tax rate −6.9 %, residual (interest, one-offs) −0.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of VERBIO Vereinigte BioEnergie AG
How large is the market capitalisation of VERBIO Vereinigte BioEnergie AG (VBK)?
The market capitalisation of VERBIO Vereinigte BioEnergie AG is €1.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of VERBIO Vereinigte BioEnergie AG (VBK)?
The price-to-sales ratio of VERBIO Vereinigte BioEnergie AG is 0.91 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of VERBIO Vereinigte BioEnergie AG (VBK)?
Earnings per share at VERBIO Vereinigte BioEnergie AG are €1.00 (price ÷ EPS = P/E 26.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of VERBIO Vereinigte BioEnergie AG (VBK)?
The dividend yield of VERBIO Vereinigte BioEnergie AG is 0.7% (payout 19.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of VERBIO Vereinigte BioEnergie AG (VBK)?
The net margin of VERBIO Vereinigte BioEnergie AG is 3.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of VERBIO Vereinigte BioEnergie AG (VBK)?
The return on equity (ROE) of VERBIO Vereinigte BioEnergie AG is 8.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of VERBIO Vereinigte BioEnergie AG (VBK)?
On an EBIT basis the return on assets of VERBIO Vereinigte BioEnergie AG is 12.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of VERBIO Vereinigte BioEnergie AG (VBK)?
The operating margin of VERBIO Vereinigte BioEnergie AG is 11.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at VERBIO Vereinigte BioEnergie AG (VBK)?
Revenue at VERBIO Vereinigte BioEnergie AG is growing +22.7% versus a year earlier (3y avg −1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at VERBIO Vereinigte BioEnergie AG (VBK)?
Earnings per share at VERBIO Vereinigte BioEnergie AG are growing +5.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does VERBIO Vereinigte BioEnergie AG (VBK) carry?
The net debt of VERBIO Vereinigte BioEnergie AG is €131M (fiscal year 2026, ≈ 1.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch VERBIO Vereinigte BioEnergie AG in the live analysis
One click puts VERBIO Vereinigte BioEnergie AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
